Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
2013 · Annals of the Rheumatic Diseases · 31 citations
https://doi.org/10.1136/annrheumdis-2013-203229
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
843
Citations
11
h-index
11
i10-index
Ingrid Louw is an academic researcher from Cape Town Science Centre. The author has contributed to research in topics: Autoimmune and Inflammatory Disorders Research & Adolescent and Pediatric Healthcare & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 11, co-authored 29 publications.
ORCID: 0000-0002-4271-0217https://doi.org/10.1136/annrheumdis-2013-203229
https://doi.org/10.1136/annrheumdis-2024-eular.1536
Click to start Chat